A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinoma

BACKGROUND: It is unclear whether cetuximab (CTX) plus cisplatin-based concurrent chemoradiotherapy (CCRT) delivers equivalent or improved results over standard CCRT in locoregionally advanced nasopharyngeal carcinoma (NPC). METHODS: The strategy involved searching the PubMed, Embase, Cochrane Libra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bi-Cheng, Shi, Liang-Liang, Fu, Chen, Zhou, Hong-Xia, Zhang, Zhan-Jie, Ding, Qian, Peng, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824634/
https://www.ncbi.nlm.nih.gov/pubmed/31626102
http://dx.doi.org/10.1097/MD.0000000000017486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824634/
https://www.ncbi.nlm.nih.gov/pubmed/31626102
http://dx.doi.org/10.1097/MD.0000000000017486

Ejemplares similares